Article Cited by others

RESEARCH PAPER

Adverse drug reaction profile of oseltamivir in children

Dalvi Prashant S, Singh Anil, Trivedi Hiren R, Mistry Suresh D, Vyas Bhadresh R

Year : 2011| Volume: 2| Issue : 2 | Page no: 100-103

   This article has been cited by
 
1 Delayed Onset of Manic Symptoms in a Patient with Influenza A (H1N1) after administration of Oseltamivir (Tamiflu): A Case Report
Min Jhon, Ju-Wan Kim, Hee-Ju Kang, Seon-Young Kim, Ju-Yeon Lee, Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim
Clinical Psychopharmacology and Neuroscience. 2021; 19(1): 166
[Pubmed]  [Google Scholar] [DOI]
2 Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases
Mario Bermúdez de León, Rafael B. R. León-Cachón, Beatriz Silva-Ramírez, Rosa Nelly González-Ríos, Brenda Escobedo-Guajardo, Roberto Leyva-Parra, Benjamín Tovar-Cisneros, Everardo González-González, Abdiel Alvarado-Díaz, Ofelia Vázquez-Monsiváis, Viviana Mata-Tijerina, Lorena Puente-Lugo, Erick Álvarez-Galván, María José Currás-Tuala, Miguel Aguado-Barrera, Fabiola Castorena-Torres, Juan Manuel Alcocer-González, Guillermo Elizondo, Ana María Salinas-Martínez
The Pharmacogenomics Journal. 2020; 20(4): 613
[Pubmed]  [Google Scholar] [DOI]
3 Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation
Sarita Rani Jaiswal, Gitali Bhagwati, Mayank Soni, Atul Thatai, Hemamalini Aiyer, Suparno Chakrabarti
Transplant Infectious Disease. 2020; 22(5)
[Pubmed]  [Google Scholar] [DOI]
4 Research Progress of Oseltamivir Phosphate
?? ?
Hans Journal of Chemical Engineering and Technology. 2020; 10(06): 449
[Pubmed]  [Google Scholar] [DOI]
5 Adverse Drug Reactions During COVID-19 Treatment
Pinar METBULUT, Emine DIBEK MISIRLIOGLU
Turkish Journal of Pediatric Disease. 2020; : 65
[Pubmed]  [Google Scholar] [DOI]
6 Suspected Oseltamivir-Induced Bradycardia in a Pediatric Patient: A Case Report from King Abdullah Specialist Children’s Hospital, Riyadh, Saudi Arabia
Hisham Arabi, Ahmed Abou Zaid, Mohammed Alreefi, Salman Alahmed
Clinics and Practice. 2018; 8(4): 102
[Pubmed]  [Google Scholar] [DOI]
7 Pharmacokinetics of oseltamivir in infants under the age of 1 year
Rashmi Dixit,Slade Matthews,Gulam Khandaker,Karen Walker,Marino Festa,Robert Booy
Clinical and Translational Medicine. 2016; 5(1)
[Pubmed]  [Google Scholar] [DOI]
8 A prospective study of adverse drug reactions to antiepileptic drugs in children
M. Anderson,O. Egunsola,J. Cherrill,C. Millward,A. Fakis,I. Choonara
BMJ Open. 2015; 5(6): e008298
[Pubmed]  [Google Scholar] [DOI]
9 Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials
Sangsang Qiu,Ye Shen,Hongqiu Pan,Jianming Wang,Qun Zhang
Infectious Diseases. 2015; 47(11): 808
[Pubmed]  [Google Scholar] [DOI]
10 Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: Comparison to procaine and bupropion
Akihiro Fukushima,Kaori Chazono,Yuichi Hashimoto,Yui Iwajima,Shohei Yamamoto,Yasuhiro Maeda,Masahiro Ohsawa,Hideki Ono
European Journal of Pharmacology. 2015; 762: 275
[Pubmed]  [Google Scholar] [DOI]
11 A prospective observational study of oseltamivir safety and tolerability in infants and young children =24?months
Barbara A. Rath,William A. Blumentals,Mary K. Miller,Kathryn Starzyk,Boguslaw Tetiurka,Martina Wollenhaupt
Pharmacoepidemiology and Drug Safety. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
12 Reduction in Sympathetic Nerve Activity as a Possible Mechanism for the Hypothermic Effect of Oseltamivir, an Anti-influenza Virus Drug, in Normal Mice
Hideki Ono,Yui Iwajima,Yuko Nagano,Kaori Chazono,Yasuhiro Maeda,Masahiro Ohsawa,Shohei Yamamoto
Basic & Clinical Pharmacology & Toxicology. 2013; 113(1): 25
[Pubmed]  [Google Scholar] [DOI]
13 Reduction in sympathetic nerve activity as a possible mechanism for the hypothermic effect of oseltamivir, an anti-influenza virus drug, in normal mice
Ono, H. and Iwajima, Y. and Nagano, Y. and Chazono, K. and Maeda, Y. and Ohsawa, M. and Yamamoto, S.
Basic and Clinical Pharmacology and Toxicology. 2013; 113(1): 25-30
[Pubmed]  [Google Scholar]
14 Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation
Yue Tang,Heyang Zhang,Xifeng Lu,Liqun Jiang,Xinyuan Xi,Jianping Liu,Jiabi Zhu
Drug Delivery. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Two years after pandemic influenza A/2009/H1N1: what have we learned?
Cheng VC, To KK, Tse H, Hung IF, Yuen KY.
Clin Microbiol Rev.. 2012; 25(2): 223-263
[Pubmed]  [Google Scholar] [DOI]
16 Antivirals used for influenza chemoprophylaxis
Tsiodras, S. and Nikolopoulos, G. and Bonovas, S.
Current Medicinal Chemistry. 2012; 19(35): 5947-5956
[Pubmed]  [Google Scholar]
17 Two seasonsæ experience with pandemic A H1N1 influenza infection in neonates
Martic, J. and Savic, N. and Jankovic, B. and Nedeljkovic, J. and Rakonjac, Z. and Pejic, K. and Markovic-Sovtic, G.
Turkish Journal of Pediatrics. 2012; 54(6): 612-616
[Pubmed]  [Google Scholar]
18 Adverse drug reaction of oseltamivir in pediatric patients
Wiwanitkit, S. and Wiwanitkit, V.
Journal of Pharmacology and Pharmacotherapeutics. 2012; 3(1): 81
[Pubmed]  [Google Scholar]

 

Read this article